Form 4: ESQ Director Zises Acquires Restricted Stock

Esquire Financial Holdings Director Selig Zises reported the acquisition of 753 shares of common stock as restricted stock, vesting in December 2026.

Summary

• Selig Zises, a Director and 10% Owner of Esquire Financial Holdings, Inc. (ESQ), acquired 753 shares of common stock.
• The acquisition occurred on December 10, 2025, at a price of $0, indicating a restricted stock grant.
• These 753 shares of restricted stock will vest 100% on December 10, 2026.
• Following this transaction, Zises beneficially owns a total of 153,850 shares, comprising 15,716 directly and 138,134 indirectly through various trusts, an L.P., and a profit-sharing plan.
• Indirect holdings include 25,500 shares as trustee for a trust, 12,600 shares by an L.P., 79,033 shares by a trust, and 21,001 shares by a profit-sharing plan.
• The reported beneficial ownership also includes other restricted stock grants with various vesting schedules commencing from December 2023 through December 2027.

Sentiment

Score: 6

Explanation: The filing reports a routine restricted stock grant to a director, which is a neutral to slightly positive event as it aligns insider interests with shareholders. There are no significant positive or negative financial implications beyond standard compensation practices.

Positives

• The acquisition of 753 shares of common stock by a director, even if restricted, aligns the director's interests with shareholders.
• The grant of restricted stock at a $0 price indicates compensation, which is a common practice for incentivizing management and directors.

Future Outlook

The filing indicates future vesting schedules for restricted stock grants, with the most recent grant of 753 shares vesting fully on December 10, 2026. Other previously granted restricted stock will continue to vest in annual installments through December 2027.

Industry Context

This Form 4 filing reports a routine insider transaction involving restricted stock compensation for a director. Such grants are standard practice across the financial services industry to align executive and director incentives with long-term shareholder value, particularly in community banking or specialized financial institutions like Esquire Financial Holdings.

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director aligns their interests with shareholders, potentially encouraging long-term value creation. It also represents a form of dilution, though typically minor for individual grants.

Next Steps

• The 753 shares of restricted stock acquired on December 10, 2025, will vest 100% on December 10, 2026.
• Other previously granted restricted stock will continue to vest in three equal annual installments on various dates through December 2027.

Key Dates

Recommendation

This Form 4 reports a standard restricted stock grant to an existing director, Selig Zises. While it aligns the director's interests with shareholders, it does not provide new information that would fundamentally alter the investment thesis for Esquire Financial Holdings. It's a routine compensation event, not indicative of significant operational changes or market-moving news, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Esquire Financial Holdings, ESQ, Selig Zises, Director, 10% Owner, Restricted Stock, Stock Grant, Beneficial Ownership, Insider Transaction, Form 4, Equity Compensation